Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase.

× No keyword cloud information.

32 in total

1. Arginine deprivation and autophagic cell death in cancer.

Authors: Peter Wojciech Szlosarek
Journal: Proc Natl Acad Sci U S A Date: 2014-09-16 Impact factor: 11.205

2. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase.

Authors: Divya Sahu; Sounak Gupta; Andrew M Hau; Kazufumi Nakashima; Mariah Z Leivo; Stephen C Searles; Paul Elson; John S Bomalaski; Darren E Casteel; Gerry R Boss; Donna E Hansel
Journal: Am J Pathol Date: 2016-12-09 Impact factor: 4.307

Review 3. Arginine dependence of tumor cells: targeting a chink in cancer's armor.

Authors: M D Patil; J Bhaumik; S Babykutty; U C Banerjee; D Fukumura
Journal: Oncogene Date: 2016-04-25 Impact factor: 9.867

4. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.

Authors: Matthew Fletcher; Maria E Ramirez; Rosa A Sierra; Patrick Raber; Paul Thevenot; Amir A Al-Khami; Dulfary Sanchez-Pino; Claudia Hernandez; Dorota D Wyczechowska; Augusto C Ochoa; Paulo C Rodriguez
Journal: Cancer Res Date: 2014-11-18 Impact factor: 12.701

5. Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.

Authors: Pankaj K Singh; Amit A Deorukhkar; Bhanu P Venkatesulu; Xiaolin Li; Ramesh Tailor; John S Bomalaski; Sunil Krishnan
Journal: Mol Cancer Ther Date: 2019-08-08 Impact factor: 6.261

Review 6. Targeting Metabolism for Cancer Therapy.

Authors: Alba Luengo; Dan Y Gui; Matthew G Vander Heiden
Journal: Cell Chem Biol Date: 2017-09-21 Impact factor: 8.116

7. Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy.

Authors: Ann E Walts; John S Bomalaski; Delma Ines; Sandra Orsulic
Journal: J Cancer Res Clin Oncol Date: 2014-12-30 Impact factor: 4.553

Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase.